Whitehouse L W, Wong L T, Paul C J, Pakuts A, Solomonraj G
Can J Physiol Pharmacol. 1985 May;63(5):431-7. doi: 10.1139/y85-075.
Male Swiss Webster mice, treated with N-acetylcysteine (NAC, 500 mg/kg po) 1 h following acetaminophen (NAPA, 350 mg/kg po) administration, had control levels of transaminases indicating that NAC protects against NAPA-induced hepatotoxicity by postabsorption antidotal mechanism(s). Hepatic congestion induced by NAPA was reduced by NAC. Significantly higher elimination rate constants (K) for indocyanine green (500 micrograms/kg, iv) in mice treated with NAPA and NAC (K = 0.676 +/- 0.062) than in animals receiving NAPA alone (0.341 +/- 0.105) suggested NAC improved or preserved the hepatic circulation of the compromised liver. This NAC-induced improvement and (or) preservation of hepatic circulation was reflected in biliary and urinary excretion of acetaminophen and its metabolites by a general increase in elimination during the first 6 h (70.2 +/- 2.6 vs. 32.6 +/- 7.1%), and in the repletion of glutathione (GSH) in the liver by a return to control levels more quickly (3 vs. greater than 5 h) following depletion by NAPA. The metabolic consequences of the postabsorption antidotal effect of NAC in the compromised liver was a preferential excretion of sulphydryl-derived metabolites in the 1-4 h bile (GSH conjugate 11.30 +/- 1.25 vs. 7.25 +/- 0.39%) which was subsequently observed in the urine by preferential excretion of glutathione degradation products.
雄性瑞士韦伯斯特小鼠在给予对乙酰氨基酚(NAPA,350mg/kg口服)1小时后,接受N-乙酰半胱氨酸(NAC,500mg/kg口服)治疗,其转氨酶水平处于对照水平,这表明NAC通过吸收后解毒机制预防NAPA诱导的肝毒性。NAC减轻了NAPA诱导的肝充血。与仅接受NAPA的动物(0.341±0.105)相比,接受NAPA和NAC治疗的小鼠(K = 0.676±0.062)对吲哚菁绿(500μg/kg,静脉注射)的消除速率常数(K)显著更高,这表明NAC改善或维持了受损肝脏的肝循环。NAC诱导的肝循环改善和(或)维持反映在对乙酰氨基酚及其代谢产物的胆汁和尿液排泄上,在最初6小时内消除总体增加(70.2±2.6对32.6±7.1%),并且在肝脏谷胱甘肽(GSH)耗竭后,通过更快恢复到对照水平(3小时对大于5小时)得以体现。NAC在受损肝脏中的吸收后解毒作用的代谢后果是在1-4小时胆汁中优先排泄巯基衍生的代谢产物(GSH共轭物11.30±1.25对7.25±0.39%),随后在尿液中通过优先排泄谷胱甘肽降解产物得以观察到。